Feb. 6, 2003 — Ertapenem once daily was as efficacious and well tolerated for intra-abdominal infections as piperacillin/tazobactam four times daily, according to ...

Approval of this indication is based on limited clinical safety and efficacy data for Emblaveo. In REVISIT, study participants with cIAI (n=312) were randomly assigned 2:1 to receive ...

For the first time since 2010, the Infectious Disease Society of America published new guidelines for treating complex abdominal infections. The revisions were prompted by “significant morbidity and ...

The FDA has approved aztreonam and avibactam (Emblaveo) in combination with metronidazole for adults who have limited or no alternative options for the treatment of complicated intra-abdominal ...

Feb 7 (Reuters) - AbbVie (ABBV.N), opens new tab said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections, including those caused by ...

Credit: Shutterstock. No significant differences in clinical cure rates were observed between short-course and prolonged-course antimicrobial therapy in patients with intraabdominal infections. SAN ...

Intra-abdominal infections (IAIs) are commonly occurring surgical and clinical emergencies that are major contributors to non-trauma deaths in the emergency room. Complicated intra-abdominal ...

The Surgical Infection Society (SIS) presents new evidence-based guidelines for the management of intra-abdominal infection (IAI) in the peer-reviewed journal Surgical Infections. Click here to read ...

man-injection-0316 The antibiotic Recarbrio is a combination of imipenem-cilastatin and relebactam. The FDA today approved Recarbrio, an antibiotic injection containing a combination of ...

The Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative options ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Merck’s three-drug combination antibiotic injection, Recarbrio, for the treatment of ...